We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
+12.8%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$237M
AUM Growth
-$4.18M
(-1.7%)
Cap. Flow
-$18.3M
Cap. Flow
% of AUM
-7.71%
Top 10 Holdings %
Top 10 Hldgs %
7.93%
Holding
416
New
61
Increased
247
Reduced
47
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.78M |
| 2 |
EOG Resources
EOG
|
+$1.78M |
| 3 |
ConocoPhillips
COP
|
+$1.72M |
| 4 |
Imperial Oil
IMO
|
+$1.64M |
| 5 |
Vornado Realty Trust
VNO
|
+$1.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ryman Hospitality Properties
RHP
|
+$2.57M |
| 2 |
Western Midstream Partners
WES
|
+$2.52M |
| 3 |
INN
Summit Hotel Properties
INN
|
+$2.43M |
| 4 |
Brookfield Renewable
BEPC
|
+$2.38M |
| 5 |
Grupo Aeroportuario del Pacifico
PAC
|
+$2.16M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.46% |
| 2 | Real Estate | 18.03% |
| 3 | Energy | 13.68% |
| 4 | Materials | 11.34% |
| 5 | Utilities | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Prothena Corp
PRTA
$448M
| $593K | 0.25% |
23,598
+423
| +2% | +$7.96K |
|
127
Regeneron Pharmaceuticals
REGN
$72.9B
| $590K | 0.25% |
1,247
+31
| +3% | +$15.1K |
|
128
Vertex Pharmaceuticals
VRTX
$124B
| $589K | 0.25% |
2,739
+71
| +3% | +$15.6K |
|
129
Ionis Pharmaceuticals
IONS
$9.14B
| $588K | 0.25% |
13,084
+359
| +3% | +$20K |
|
130
Incyte
INCY
$26B
| $585K | 0.25% |
7,204
+193
| +3% | +$16.5K |
|
131
MidCap Financial Investment
MFIC
$811M
| $583K | 0.25% |
42,505
-12,389
| -23% | -$164K |
|
132
BlackRock TCP Capital
TCPC
$274M
| $579K | 0.24% |
41,836
+2,395
| +6% | +$30.4K |
|
133
Ironwood Pharmaceuticals
IRWD
$626M
| $574K | 0.24% |
51,311
+1,403
| +3% | +$14.8K |
|
|
DVAX
134
DELISTED
Dynavax Technologies
DVAX
| $571K | 0.24% |
58,090
+1,028
| +2% | +$8.47K |
|
135
BioMarin Pharmaceuticals
BMRN
$12B
| $570K | 0.24% |
7,550
+204
| +3% | +$16.7K |
|
|
MORF
136
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $565K | 0.24% |
8,928
+150
| +2% | +$6.88K |
|
137
Fidus Investment
FDUS
$766M
| $553K | 0.23% |
35,532
+3,112
| +10% | +$44.4K |
|
|
PNNT
138
Pennant Park Investment Corp
PNNT
$221M
| $549K | 0.23% |
97,135
-40,625
| -29% | -$222K |
|
139
Insmed
INSM
$22.6B
| $534K | 0.23% |
15,678
+426
| +3% | +$16.3K |
|
140
Oaktree Specialty Lending
OCSL
$1.06B
| $531K | 0.22% |
28,547
+11,992
| +72% | +$216K |
|
141
Moderna
MRNA
$22.1B
| $528K | 0.22% |
4,031
+106
| +3% | +$15.4K |
|
142
WhiteHorse Finance
WHF
$139M
| $528K | 0.22% |
34,775
+6,198
| +22% | +$89.6K |
|
|
BPMC
143
DELISTED
Blueprint Medicines
BPMC
| $519K | 0.22% |
5,334
+146
| +3% | +$14.6K |
|
144
Capital Southwest
CSWC
$1.48B
| $506K | 0.21% |
22,813
-4,374
| -16% | -$89.3K |
|
145
Harmony Biosciences
HRMY
$2.07B
| $506K | 0.21% |
15,322
+423
| +3% | +$14.8K |
|
146
New Mountain Finance
NMFC
$668M
| $502K | 0.21% |
40,512
+2,818
| +7% | +$34.4K |
|
147
Goldman Sachs BDC
GSBD
$1,000M
| $500K | 0.21% |
25,885
+4,853
| +23% | +$90.9K |
|
|
BGX
148
Blackstone Long-Short Credit Income Fund
BGX
$136M
| $493K | 0.21% |
34,869
+3,439
| +11% | +$47.9K |
|
|
DCPH
149
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $492K | 0.21% |
10,979
+298
| +3% | +$13.9K |
|
|
BHVN
150
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $492K | 0.21% |
7,193
+196
| +3% | +$15.9K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
RC
Virtus ETF Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, Virtus ETF Advisers held 416 positions worth $237M, down 1.7% from $241M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Virtus ETF Advisers withdrew a net $18.3M in Q1 2021, closing 61 positions and reducing 47 holdings. Its most notable exit was Ryman Hospitality Properties, an estimated $2.57M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Real Estate and Energy.
Against the trend, Virtus ETF Advisers opened a new position in Pioneer Natural Resource Co. worth $1.99M.
- Virtus ETF Advisers's largest Q1 2021 buy was Pioneer Natural Resource Co.: 12,538 shares worth $1.99M.
- Virtus ETF Advisers added most to Oaktree Specialty Lending in Q1 2021, an estimated $216K increase.
- Virtus ETF Advisers's biggest Q1 2021 reduction was Avient, cutting an estimated $916K.
- Virtus ETF Advisers fully exited Ryman Hospitality Properties in Q1 2021, selling an estimated $2.57M.
- Virtus ETF Advisers's ten largest holdings make up 7.9% of its $237M portfolio in Q1 2021.
- Virtus ETF Advisers opened 61 new positions and closed 61 in Q1 2021.
- Virtus ETF Advisers's portfolio value fell 1.7% quarter-over-quarter to $237M.
Based on Virtus ETF Advisers's 13F filing for Q1 2021, filed 17 May 2021.